These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 69552)
1. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Stevenson GT; Elliott EV; Stevenson FK Fed Proc; 1977 Aug; 36(9):2268-71. PubMed ID: 69552 [No Abstract] [Full Text] [Related]
2. Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes: implications for immunotherapy. Elliott TJ; Glennie MJ; McBride HM; Stevenson GT J Immunol; 1987 Feb; 138(3):981-8. PubMed ID: 2433338 [TBL] [Abstract][Full Text] [Related]
3. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions. Gordon J; Anderson VA; Stevenson GT J Immunol; 1982 Jun; 128(6):2863-9. PubMed ID: 6804570 [TBL] [Abstract][Full Text] [Related]
4. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin. Stevenson FK; Elliott EV; Stevenson GT Immunology; 1977 Apr; 32(4):549-57. PubMed ID: 415966 [TBL] [Abstract][Full Text] [Related]
6. Immunological studies of the guinea pig L2C leukemia. Green I; Forni G; Konen T; Hu CP; Schwartz BD; Kask A; Shevach EM Fed Proc; 1977 Aug; 36(9):2264-7. PubMed ID: 328308 [No Abstract] [Full Text] [Related]
7. A study of the variable heavy chain (VH) region of membrane-bound Ig on human chronic leukemic lymphocytes. Forre O; Froland SS; Natvig JB; Michaelsen TE; Johnson PM; Ly B; Laake K J Immunol; 1977 May; 118(5):1513-6. PubMed ID: 404355 [TBL] [Abstract][Full Text] [Related]
8. Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies. Haegert DG; Timm M Immunology; 1983 Nov; 50(3):447-59. PubMed ID: 6195097 [TBL] [Abstract][Full Text] [Related]
9. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation. Stevenson FK; Gordon J J Immunol; 1983 Feb; 130(2):970-3. PubMed ID: 6600259 [TBL] [Abstract][Full Text] [Related]
10. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants. Stevenson FK; Elliott EV Immunology; 1978 Feb; 34(2):353-8. PubMed ID: 75184 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM. Perek Y; Hurwitz E; Burowski D; Haimovich J J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513 [TBL] [Abstract][Full Text] [Related]
13. Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. Fu SM; Winchester RJ; Kunkel HG J Immunol; 1975 Jan; 114(1 Pt 1):250-2. PubMed ID: 803528 [TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity. Ciavarra RP; Vitetta ES; Forman J J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362 [TBL] [Abstract][Full Text] [Related]
15. Mutant lines of guinea pig L2C leukemia. III. The reaction of an alloantiserum detecting idiotypic determinants on a clonally derived guinea pig B cell leukemia with IgM and Ia molecules. Konen TG; Green I; Shevach EM; Kask AM; Schwartz BD J Immunol; 1976 Nov; 117(5 Pt.2):1966-70. PubMed ID: 62799 [TBL] [Abstract][Full Text] [Related]
16. The binding of IgM aggregates to neoplastic B lymphocytes. II. Fc dependence and implications for a model of B lymphocyte differentiation. Rudders RA; Andersen J; Fried R J Immunol; 1980 May; 124(5):2347-51. PubMed ID: 6767785 [No Abstract] [Full Text] [Related]
17. In vivo activation of quiescent B cells by anti-immunoglobulin. I. Induction of latent VH allotype production in adult rabbits by treatment with heterologous antibodies or antibody fragments. Metzger DW; Fried VA; Van Cleave VH J Immunol; 1987 May; 138(9):2982-7. PubMed ID: 2437201 [TBL] [Abstract][Full Text] [Related]
18. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM. Qian GX; Fu SM; Solanki DL; Rai KR J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459 [TBL] [Abstract][Full Text] [Related]
19. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes. Hough DW; Eady RP; Hamblin TJ; Stevenson FK; Stevenson GT J Exp Med; 1976 Oct; 144(4):960-9. PubMed ID: 62018 [TBL] [Abstract][Full Text] [Related]
20. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia]. López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142 [No Abstract] [Full Text] [Related] [Next] [New Search]